Global conjugate vaccine market statistics, by regions, 2018-2030 (USD Million)
Global conjugate vaccine market outlook by product size was valued at 19,012.1 USD million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030.
Global conjugate vaccine market statistics, by regions, 2018-2030 (USD Million)
Conjugate Vaccine Market Scope
Conjugate vaccine market segmentation & scope
Brand
Prevnar
Synflorix
PedvaxHIB
Hiberix
ACT-HIB
Pentacel
Menveo
Menactra
MenQuadfi
VAXNEUVANCE
CAPVAXIVE
Others
Disease
Pneumococcal
Influenza
DTP
Meningococcal
Typhoid
Pathogen
Bacterial
Viral
Combination
Patient
Pediatric
Adults
Countries
U.S.
Canada
Mexico
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Conjugate Vaccine Market Outlook
- HTML
- PPT
- -
Everything on Conjugate Vaccine Market Outlook in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
